Effectiveness of monovalent COVID-19 booster/additional vaccine doses in the United States

Effectiveness of monovalent COVID-19 booster/additional vaccine doses in the United States

Background: Monovalent booster/additional doses of COVID-19 vaccines were first authorized in August 2021 in the United States. We evaluated the real-world effectiveness of receipt of a monovalent booster/additional dose of COVID-19 vaccine compared with receiving a primary vaccine series without a...

Full description

Bibliographic Details
Main Authors: J. Bradley Layton, Lauren Peetluk, Hui Lee Wong, Yixin Jiao, Djeneba Audrey Djibo, Christine Bui, Patricia C. Lloyd, Joann F. Gruber, Michael Miller, Rachel P. Ogilvie, Jie Deng, Ron Parambi, Jennifer Song, Lisa B. Weatherby, An-Chi Lo, Kathryn Matuska, Michael Wernecke, Tainya C. Clarke, Sylvia Cho, Elizabeth J. Bell, John D. Seeger, Grace Wenya Yang, Dóra Illei, Richard A. Forshee, Steven A. Anderson, Cheryl N. McMahill-Walraven, Yoganand Chillarige, Kandace L. Amend, Mary S. Anthony, Azadeh Shoaibi
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Vaccine: X
Subjects:
COVID-19 vaccines
Pharmacoepidemiology
Vaccine effectiveness
Online Access:http://www.sciencedirect.com/science/article/pii/S2590136224000202

Internet

http://www.sciencedirect.com/science/article/pii/S2590136224000202

Similar Items